Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis

AimsTo determine the long-term visual and systemic outcomes of uveitis patients with biopsy-proven sarcoidosis.MethodsA retrospective study of biopsy-proven sarcoid uveitis, with a 3-year minimum follow-up, seen at Lyon University Hospital, between April 2004 and January 2016.ResultsA total of 83 pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of ophthalmology 2017-07, Vol.101 (7), p.856-861
Hauptverfasser: Rochepeau, Cédric, Jamilloux, Yvan, Kerever, Sebastien, Febvay, Camille, Perard, Laurent, Broussolle, Christiane, Burillon, Carole, Kodjikian, Laurent, Seve, Pascal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 861
container_issue 7
container_start_page 856
container_title British journal of ophthalmology
container_volume 101
creator Rochepeau, Cédric
Jamilloux, Yvan
Kerever, Sebastien
Febvay, Camille
Perard, Laurent
Broussolle, Christiane
Burillon, Carole
Kodjikian, Laurent
Seve, Pascal
description AimsTo determine the long-term visual and systemic outcomes of uveitis patients with biopsy-proven sarcoidosis.MethodsA retrospective study of biopsy-proven sarcoid uveitis, with a 3-year minimum follow-up, seen at Lyon University Hospital, between April 2004 and January 2016.ResultsA total of 83 patients were included, with a median age at onset of 52 (37−62) years and an unbalanced gender ratio (women 77.1%). Thirty-one patients had original systemic sarcoidosis in addition to ocular localisation, whereas 52 initially presented with isolated sarcoid uveitis. Among the latter, 7.7% (n=4) developed an extraocular disease after a median follow-up duration of 60 (44−110) months. The systemic spread in these patients included cutaneous sarcoids (n=2), arthritis (n=1) and multiple mononeuritis (n=1). Complete visual recovery was obtained for 60.2% of all patients and 89.2% had retrieved best-corrected visual acuity (BCVA) >20/50 in both eyes. A unilateral loss of BCVA of worse than 20/200 was documented in two patients in the isolated sarcoid uveitis group. No patient suffered from bilateral severe visual impairment or blindness. Factors linked to a poor visual prognosis, defined by BCVA ≤20/50 in at least one eye, were chronic macular oedema (p=0.009) and persistent ocular inflammation (p=0.0005).ConclusionsIn this large European series of biopsy-proven sarcoidosis to date, with a prolonged follow-up, sarcoid uveitis was suggestive of a favourable systemic and visual outcome. Clinically isolated uveitis that revealed sarcoidosis remained a strictly ocular condition in most cases.
doi_str_mv 10.1136/bjophthalmol-2016-309767
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01799998v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3109647864</sourcerecordid><originalsourceid>FETCH-LOGICAL-b527t-96612b059cc38c0c95143eebe50281f5905668be0c938c3996838bf2e03f2fcd3</originalsourceid><addsrcrecordid>eNqVkU1PwzAMhiMEYmPwF1AkThwKcdLm4zhNwJAmcRnnqMnSrdPajKadtH9Ppo7BCUQuie3nta28CGEgDwCMP5q1367aVb6p_CahBHjCiBJcnKEhpFzGlFDnaEgIEQkAhwG6CmEdQ8pBXKIBFVJKkGyI5jNfL5PWNRXelaHLNzivFzjsQ-uq0uJt45e1Dy5gX2DJsM2Pb1P6bdgnsb5zNQ55Y325wN3OlW0ZrtFFkW-CuzneI_T-_DSfTJPZ28vrZDxLTEZFmyjOgRqSKWuZtMSqDFLmnHEZoRKKTJGMc2lcrMQ6U4pLJk1BHWEFLeyCjdB93zf-hN42ZZU3e-3zUk_HM33IERAqHrmDyN71bFz5o3Oh1WvfNXVcTzMgiqdC8vQ3ChSkRDJKs0jJnrKND6FxxWk4EH0wSP80SB8M0r1BUXp7HNCZyi1Owi9HIsB6wFTr_7RNv1XfK_8l-wTK5q_a</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1914083225</pqid></control><display><type>article</type><title>Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis</title><source>MEDLINE</source><source>PubMed Central</source><creator>Rochepeau, Cédric ; Jamilloux, Yvan ; Kerever, Sebastien ; Febvay, Camille ; Perard, Laurent ; Broussolle, Christiane ; Burillon, Carole ; Kodjikian, Laurent ; Seve, Pascal</creator><creatorcontrib>Rochepeau, Cédric ; Jamilloux, Yvan ; Kerever, Sebastien ; Febvay, Camille ; Perard, Laurent ; Broussolle, Christiane ; Burillon, Carole ; Kodjikian, Laurent ; Seve, Pascal</creatorcontrib><description>AimsTo determine the long-term visual and systemic outcomes of uveitis patients with biopsy-proven sarcoidosis.MethodsA retrospective study of biopsy-proven sarcoid uveitis, with a 3-year minimum follow-up, seen at Lyon University Hospital, between April 2004 and January 2016.ResultsA total of 83 patients were included, with a median age at onset of 52 (37−62) years and an unbalanced gender ratio (women 77.1%). Thirty-one patients had original systemic sarcoidosis in addition to ocular localisation, whereas 52 initially presented with isolated sarcoid uveitis. Among the latter, 7.7% (n=4) developed an extraocular disease after a median follow-up duration of 60 (44−110) months. The systemic spread in these patients included cutaneous sarcoids (n=2), arthritis (n=1) and multiple mononeuritis (n=1). Complete visual recovery was obtained for 60.2% of all patients and 89.2% had retrieved best-corrected visual acuity (BCVA) &gt;20/50 in both eyes. A unilateral loss of BCVA of worse than 20/200 was documented in two patients in the isolated sarcoid uveitis group. No patient suffered from bilateral severe visual impairment or blindness. Factors linked to a poor visual prognosis, defined by BCVA ≤20/50 in at least one eye, were chronic macular oedema (p=0.009) and persistent ocular inflammation (p=0.0005).ConclusionsIn this large European series of biopsy-proven sarcoidosis to date, with a prolonged follow-up, sarcoid uveitis was suggestive of a favourable systemic and visual outcome. Clinically isolated uveitis that revealed sarcoidosis remained a strictly ocular condition in most cases.</description><identifier>ISSN: 0007-1161</identifier><identifier>EISSN: 1468-2079</identifier><identifier>DOI: 10.1136/bjophthalmol-2016-309767</identifier><identifier>PMID: 27888183</identifier><language>eng</language><publisher>BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd</publisher><subject>Adult ; Anterior Eye Segment - pathology ; Arthritis ; Asymptomatic ; Biopsy ; Biopsy - methods ; Blindness ; Cancer ; Clinical science ; Disease ; Disease Progression ; Edema ; Epidemiology ; Exocrine glands ; Female ; Fluorescein Angiography - methods ; Follow-Up Studies ; Fundus Oculi ; Granulomas ; Health maintenance organizations ; HMOs ; Humans ; Inflammation ; Life Sciences ; Lymphatic system ; Male ; Medical imaging ; Medical prognosis ; Middle Aged ; Nervous system ; Ophthalmology ; Prognosis ; Retrospective Studies ; Sarcoidosis ; Sarcoidosis - diagnosis ; Sarcoidosis - physiopathology ; Time Factors ; Tomography ; Tomography, Optical Coherence - methods ; Tomography, X-Ray Computed ; Ultrasonic imaging ; Uveitis - diagnosis ; Uveitis - physiopathology ; Variables ; Visual Acuity ; Visual impairment ; White people ; X-rays</subject><ispartof>British journal of ophthalmology, 2017-07, Vol.101 (7), p.856-861</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.</rights><rights>Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/2016</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b527t-96612b059cc38c0c95143eebe50281f5905668be0c938c3996838bf2e03f2fcd3</citedby><cites>FETCH-LOGICAL-b527t-96612b059cc38c0c95143eebe50281f5905668be0c938c3996838bf2e03f2fcd3</cites><orcidid>0000-0001-5249-3650 ; 0000-0002-3908-6716</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27888183$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01799998$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Rochepeau, Cédric</creatorcontrib><creatorcontrib>Jamilloux, Yvan</creatorcontrib><creatorcontrib>Kerever, Sebastien</creatorcontrib><creatorcontrib>Febvay, Camille</creatorcontrib><creatorcontrib>Perard, Laurent</creatorcontrib><creatorcontrib>Broussolle, Christiane</creatorcontrib><creatorcontrib>Burillon, Carole</creatorcontrib><creatorcontrib>Kodjikian, Laurent</creatorcontrib><creatorcontrib>Seve, Pascal</creatorcontrib><title>Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis</title><title>British journal of ophthalmology</title><addtitle>Br J Ophthalmol</addtitle><addtitle>Br J Ophthalmol</addtitle><description>AimsTo determine the long-term visual and systemic outcomes of uveitis patients with biopsy-proven sarcoidosis.MethodsA retrospective study of biopsy-proven sarcoid uveitis, with a 3-year minimum follow-up, seen at Lyon University Hospital, between April 2004 and January 2016.ResultsA total of 83 patients were included, with a median age at onset of 52 (37−62) years and an unbalanced gender ratio (women 77.1%). Thirty-one patients had original systemic sarcoidosis in addition to ocular localisation, whereas 52 initially presented with isolated sarcoid uveitis. Among the latter, 7.7% (n=4) developed an extraocular disease after a median follow-up duration of 60 (44−110) months. The systemic spread in these patients included cutaneous sarcoids (n=2), arthritis (n=1) and multiple mononeuritis (n=1). Complete visual recovery was obtained for 60.2% of all patients and 89.2% had retrieved best-corrected visual acuity (BCVA) &gt;20/50 in both eyes. A unilateral loss of BCVA of worse than 20/200 was documented in two patients in the isolated sarcoid uveitis group. No patient suffered from bilateral severe visual impairment or blindness. Factors linked to a poor visual prognosis, defined by BCVA ≤20/50 in at least one eye, were chronic macular oedema (p=0.009) and persistent ocular inflammation (p=0.0005).ConclusionsIn this large European series of biopsy-proven sarcoidosis to date, with a prolonged follow-up, sarcoid uveitis was suggestive of a favourable systemic and visual outcome. Clinically isolated uveitis that revealed sarcoidosis remained a strictly ocular condition in most cases.</description><subject>Adult</subject><subject>Anterior Eye Segment - pathology</subject><subject>Arthritis</subject><subject>Asymptomatic</subject><subject>Biopsy</subject><subject>Biopsy - methods</subject><subject>Blindness</subject><subject>Cancer</subject><subject>Clinical science</subject><subject>Disease</subject><subject>Disease Progression</subject><subject>Edema</subject><subject>Epidemiology</subject><subject>Exocrine glands</subject><subject>Female</subject><subject>Fluorescein Angiography - methods</subject><subject>Follow-Up Studies</subject><subject>Fundus Oculi</subject><subject>Granulomas</subject><subject>Health maintenance organizations</subject><subject>HMOs</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Life Sciences</subject><subject>Lymphatic system</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Nervous system</subject><subject>Ophthalmology</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Sarcoidosis</subject><subject>Sarcoidosis - diagnosis</subject><subject>Sarcoidosis - physiopathology</subject><subject>Time Factors</subject><subject>Tomography</subject><subject>Tomography, Optical Coherence - methods</subject><subject>Tomography, X-Ray Computed</subject><subject>Ultrasonic imaging</subject><subject>Uveitis - diagnosis</subject><subject>Uveitis - physiopathology</subject><subject>Variables</subject><subject>Visual Acuity</subject><subject>Visual impairment</subject><subject>White people</subject><subject>X-rays</subject><issn>0007-1161</issn><issn>1468-2079</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqVkU1PwzAMhiMEYmPwF1AkThwKcdLm4zhNwJAmcRnnqMnSrdPajKadtH9Ppo7BCUQuie3nta28CGEgDwCMP5q1367aVb6p_CahBHjCiBJcnKEhpFzGlFDnaEgIEQkAhwG6CmEdQ8pBXKIBFVJKkGyI5jNfL5PWNRXelaHLNzivFzjsQ-uq0uJt45e1Dy5gX2DJsM2Pb1P6bdgnsb5zNQ55Y325wN3OlW0ZrtFFkW-CuzneI_T-_DSfTJPZ28vrZDxLTEZFmyjOgRqSKWuZtMSqDFLmnHEZoRKKTJGMc2lcrMQ6U4pLJk1BHWEFLeyCjdB93zf-hN42ZZU3e-3zUk_HM33IERAqHrmDyN71bFz5o3Oh1WvfNXVcTzMgiqdC8vQ3ChSkRDJKs0jJnrKND6FxxWk4EH0wSP80SB8M0r1BUXp7HNCZyi1Owi9HIsB6wFTr_7RNv1XfK_8l-wTK5q_a</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Rochepeau, Cédric</creator><creator>Jamilloux, Yvan</creator><creator>Kerever, Sebastien</creator><creator>Febvay, Camille</creator><creator>Perard, Laurent</creator><creator>Broussolle, Christiane</creator><creator>Burillon, Carole</creator><creator>Kodjikian, Laurent</creator><creator>Seve, Pascal</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-5249-3650</orcidid><orcidid>https://orcid.org/0000-0002-3908-6716</orcidid></search><sort><creationdate>20170701</creationdate><title>Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis</title><author>Rochepeau, Cédric ; Jamilloux, Yvan ; Kerever, Sebastien ; Febvay, Camille ; Perard, Laurent ; Broussolle, Christiane ; Burillon, Carole ; Kodjikian, Laurent ; Seve, Pascal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b527t-96612b059cc38c0c95143eebe50281f5905668be0c938c3996838bf2e03f2fcd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Anterior Eye Segment - pathology</topic><topic>Arthritis</topic><topic>Asymptomatic</topic><topic>Biopsy</topic><topic>Biopsy - methods</topic><topic>Blindness</topic><topic>Cancer</topic><topic>Clinical science</topic><topic>Disease</topic><topic>Disease Progression</topic><topic>Edema</topic><topic>Epidemiology</topic><topic>Exocrine glands</topic><topic>Female</topic><topic>Fluorescein Angiography - methods</topic><topic>Follow-Up Studies</topic><topic>Fundus Oculi</topic><topic>Granulomas</topic><topic>Health maintenance organizations</topic><topic>HMOs</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Life Sciences</topic><topic>Lymphatic system</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Nervous system</topic><topic>Ophthalmology</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Sarcoidosis</topic><topic>Sarcoidosis - diagnosis</topic><topic>Sarcoidosis - physiopathology</topic><topic>Time Factors</topic><topic>Tomography</topic><topic>Tomography, Optical Coherence - methods</topic><topic>Tomography, X-Ray Computed</topic><topic>Ultrasonic imaging</topic><topic>Uveitis - diagnosis</topic><topic>Uveitis - physiopathology</topic><topic>Variables</topic><topic>Visual Acuity</topic><topic>Visual impairment</topic><topic>White people</topic><topic>X-rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rochepeau, Cédric</creatorcontrib><creatorcontrib>Jamilloux, Yvan</creatorcontrib><creatorcontrib>Kerever, Sebastien</creatorcontrib><creatorcontrib>Febvay, Camille</creatorcontrib><creatorcontrib>Perard, Laurent</creatorcontrib><creatorcontrib>Broussolle, Christiane</creatorcontrib><creatorcontrib>Burillon, Carole</creatorcontrib><creatorcontrib>Kodjikian, Laurent</creatorcontrib><creatorcontrib>Seve, Pascal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>British journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rochepeau, Cédric</au><au>Jamilloux, Yvan</au><au>Kerever, Sebastien</au><au>Febvay, Camille</au><au>Perard, Laurent</au><au>Broussolle, Christiane</au><au>Burillon, Carole</au><au>Kodjikian, Laurent</au><au>Seve, Pascal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis</atitle><jtitle>British journal of ophthalmology</jtitle><stitle>Br J Ophthalmol</stitle><addtitle>Br J Ophthalmol</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>101</volume><issue>7</issue><spage>856</spage><epage>861</epage><pages>856-861</pages><issn>0007-1161</issn><eissn>1468-2079</eissn><abstract>AimsTo determine the long-term visual and systemic outcomes of uveitis patients with biopsy-proven sarcoidosis.MethodsA retrospective study of biopsy-proven sarcoid uveitis, with a 3-year minimum follow-up, seen at Lyon University Hospital, between April 2004 and January 2016.ResultsA total of 83 patients were included, with a median age at onset of 52 (37−62) years and an unbalanced gender ratio (women 77.1%). Thirty-one patients had original systemic sarcoidosis in addition to ocular localisation, whereas 52 initially presented with isolated sarcoid uveitis. Among the latter, 7.7% (n=4) developed an extraocular disease after a median follow-up duration of 60 (44−110) months. The systemic spread in these patients included cutaneous sarcoids (n=2), arthritis (n=1) and multiple mononeuritis (n=1). Complete visual recovery was obtained for 60.2% of all patients and 89.2% had retrieved best-corrected visual acuity (BCVA) &gt;20/50 in both eyes. A unilateral loss of BCVA of worse than 20/200 was documented in two patients in the isolated sarcoid uveitis group. No patient suffered from bilateral severe visual impairment or blindness. Factors linked to a poor visual prognosis, defined by BCVA ≤20/50 in at least one eye, were chronic macular oedema (p=0.009) and persistent ocular inflammation (p=0.0005).ConclusionsIn this large European series of biopsy-proven sarcoidosis to date, with a prolonged follow-up, sarcoid uveitis was suggestive of a favourable systemic and visual outcome. Clinically isolated uveitis that revealed sarcoidosis remained a strictly ocular condition in most cases.</abstract><cop>BMA House, Tavistock Square, London, WC1H 9JR</cop><pub>BMJ Publishing Group Ltd</pub><pmid>27888183</pmid><doi>10.1136/bjophthalmol-2016-309767</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-5249-3650</orcidid><orcidid>https://orcid.org/0000-0002-3908-6716</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0007-1161
ispartof British journal of ophthalmology, 2017-07, Vol.101 (7), p.856-861
issn 0007-1161
1468-2079
language eng
recordid cdi_hal_primary_oai_HAL_hal_01799998v1
source MEDLINE; PubMed Central
subjects Adult
Anterior Eye Segment - pathology
Arthritis
Asymptomatic
Biopsy
Biopsy - methods
Blindness
Cancer
Clinical science
Disease
Disease Progression
Edema
Epidemiology
Exocrine glands
Female
Fluorescein Angiography - methods
Follow-Up Studies
Fundus Oculi
Granulomas
Health maintenance organizations
HMOs
Humans
Inflammation
Life Sciences
Lymphatic system
Male
Medical imaging
Medical prognosis
Middle Aged
Nervous system
Ophthalmology
Prognosis
Retrospective Studies
Sarcoidosis
Sarcoidosis - diagnosis
Sarcoidosis - physiopathology
Time Factors
Tomography
Tomography, Optical Coherence - methods
Tomography, X-Ray Computed
Ultrasonic imaging
Uveitis - diagnosis
Uveitis - physiopathology
Variables
Visual Acuity
Visual impairment
White people
X-rays
title Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T14%3A16%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20visual%20and%20systemic%20prognoses%20of%2083%20cases%20of%20biopsy-proven%20sarcoid%20uveitis&rft.jtitle=British%20journal%20of%20ophthalmology&rft.au=Rochepeau,%20C%C3%A9dric&rft.date=2017-07-01&rft.volume=101&rft.issue=7&rft.spage=856&rft.epage=861&rft.pages=856-861&rft.issn=0007-1161&rft.eissn=1468-2079&rft_id=info:doi/10.1136/bjophthalmol-2016-309767&rft_dat=%3Cproquest_hal_p%3E3109647864%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1914083225&rft_id=info:pmid/27888183&rfr_iscdi=true